ROBOT-ASSISTED VERSUS LAPAROSCOPIC RECTAL RESECTION FOR CANCER IN A SINGLE SURGEON’S EXPERIENCE: A COST-ANALYSIS, COVERING THE INITIAL 50 ROBOTIC CASES by Morelli, Luca et al.
110
ABSTRACTS
P149
PROGNOSTIC IMPACT OF PREOPERATIVE CHEMORADIOTHERAPY IN
PATIENTS WITH LOCALLY ADVANCED LOW RECTAL CANCER HAVING
LATERAL PELVIC LYMPH NODE METASTASES.
T. Akiyoshi, T. Nagasaki, T. konishi, Y. Fujimoto, S. Nagayama,
Y. Fukunaga and M. Ueno Department of Gastroenterological Surgery,
Cancer Institute Hospital, Tokyo, Japan.
Purpose: Although preoperative chemoradiotherapy (CRT) is a stan-
dard treatment for patients with locally advanced low rectal cancer (LALRC),
the prognostic significance of preoperative CRT in patients with lateral
lymph node metastases (LLNM) is unknown. The aim of the present study
was to examine the prognostic impact of preoperative CRT in patients with
LALRC having LLNM.
Methods: From 1985 to 2012, we analyzed 73 patients with LALRC hav-
ing LLNM who underwent total mesorectal excision and lateral lymph node
dissection. Patient population was subdivided into the CRT group (N = 30)
who were treated with preoperative CRT and the surgery alone group (N =
43) who were treated without CRT. Clinicopathological characteristics were
compared between the two groups. Furthermore, univariate and multivari-
ate analysis were performed to assess the predictors of overall survival (OS),
relapse-frees survival (RFS) and local recurrence (LR) rate.
Results: Forty-six (63.0%) were male and 27 (37.0%) were female
patients. Sixty-eight patients (93.2%) underwent R0 resection, but five
patients (6.8%) had positive circumferential resection margin. The median
distance of the tumor from the anal verge was 40 mm in both groups. The
number of total, mesorectal, and LLNM were significantly smaller in the CRT
group than in the surgery alone group. Five-year OS, RFS and LR rate of the
CRT group were significantly better (78.2, 72.1 and 3.5%, respectively) than
those of the surgery alone group (41.1, 25.4 and 39.6%, respectively). Mul-
tivariate analysis showed that surgery without CRT was an independent
worse predictor of OS (HR 3.513, P = 0.004), RFS (HR 2.696, P = 0.021) and
LR rate (HR 11.094, P = 0.001). A total number of lymph node metastasis ≥4
was also independent worse predictor of OS and RFS.
Conclusions: Preoperative CRT might have significant prognostic
impact on patients with LALRC with LLNM treated with total mesorectal
excision and lateral lymph node dissection. Preoperative CRT and lateral
lymph node dissection should be considered for LALRC with suspected
LLNM.
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ROBOT-ASSISTED VERSUS LAPAROSCOPIC RECTAL RESECTION FOR
CANCER IN A SINGLE SURGEON’S EXPERIENCE: A COST-ANALYSIS,
COVERING THE INITIAL 50 ROBOTIC CASES.
L. Morelli1, L. Cobuccio1, V. Lorenzoni3, S. Guadagni1, M. Palmeri1, G. Di
Franco1, G. Turchetti3 and F. Mosca2 1General Surgery, Department of
Oncology Transplantation and New Technologies, University of Pisa, Pisa,
Italy, 2EndoCAS (Center for Computer Assisted Surgery), University of Pisa,
Pisa, Italy and 3Scuola Superiore S. Anna, University of Pisa, Pisa, Italy.
Purpose: Since the introduction of the da Vinci® Surgical System, sev-
eral studies have been published regarding the clinical and surgical bene-
fits of robot-assisted colorectal surgery, but, only a few have reported a
structured cost-analysis. The aim of this study is to compare surgical param-
eters and costs of robotic surgery with those of laparoscopic approach in
rectal cancer based on a single surgeon’s early robotic experience.
Methods: Data from the first 50 robotic (ROB) and from 25 laparoscopic
(LAP), rectal resections performed at our institution by an experienced
laparoscopic surgeon (>500 procedures) between 2009 to 2014, were col-
lected, retrospectively analyzed and compared. Patient demographic, pro-
cedure and outcome data were gathered. Financial costs of the two proce-
dures were collected and categorized into fixed and variable costs. The
robotic learning curve was analyzed using the cumulative sum method
(CUSUM).
Results: Based on CUSUM analysis, ROB group was divided into 3
phases (ROB1: 1-19; ROB2: 20-40; ROB3: 41-50). Overall median operating
time was significantly lower in LAP than in ROB (270 min vs 312.5 min,
P=0.006) and regression analysis showed a borderline significant interac-
tion effect between type of surgery and year (P=0.058) suggesting a signif-
icant reduction of operating time only in ROB group. Length of hospital stay
did not differ between groups (P=0.567). Overall mean costs associated
with LAP procedures were significantly lower than ROB (P<0.001). A statis-
tically significant reduction in variable and fixed costs were found between
ROB3 and ROB1 (P<0.05). If we exclude fixed costs, the difference between
laparoscopic and ROB3 were no longer statistically significant.
Conclusions: Even if our results suggest a significant optimization of
costs with increased experience, robotic rectal surgery has significantly
greater costs and operating times compared to standard laparoscopy. The
dominant cost is fixed cost and efforts to reduce it include accurate patient
selection and use in high volume, multidisciplinary centers.
*Adjusted for Age and adjuvant therapy
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THE BIMODAL ASSOCIATION BETWEEN PATHOLOGIC COMPLETE
RESPONSE AND TUMOR HEIGHT IN LOCALLY ADVANCED RECTAL
CANCER PATIENTS UNDERGOING NEOADJUVANT THERAPY.
S. V. Patel, J. Smith, G. Nash, L. Temple, J. Guillem, P. Paty, J. Garcia-
Aguilar and M. Weiser Colorectal Surgery, Memorial Sloan Kettering
Cancer Center, New York, NY.
Purpose: Neoadjuvant therapy is standard for locally advanced (AJCC
stage II and III) rectal cancer. Achieving a pathologic complete response
(pCR) has been associated with better prognosis when compared to
patients achieving an incomplete response. The objective of this study was
to investigate the relationship between distance to the anal verge (DTAV)
and pCR.
Methods: Review of a tertiary cancer center’s prospectively maintained
database identified 827 patients with locally advanced rectal cancer who
received neoadjuvant treatment, long-course radiation with concomitant
5-Fluorouracil chemotherapy over 25-28 fractions, during the study period
(1998 – 2011). Univariate and multivariate analysis were undertaken to
determine association between tumor height from the anal verge (mea-
sured pretreatment with proctoscopy) along with other covariates and
tumor response to neoadjuvant therapy.
Results: Of the 827 included patients, the median height of the distal
aspect of the tumor from the anal verge was 7 cm (IQR 5 – 9 cm). 165
patients (20.0%) had a pCR. DTAV was strongly associated with pCR (P =
0.002): pCR rates were 11.0% for tumors ≤ 4.0 cm, 23.9% for tumors 4.1-6.0
cm, 29.9% for tumors at 6.1-8.0 cm, 16.6% for tumors 8.1 – 10.0 cm (16.6%)
and 13.6% for tumors > 10 cm from the anal verge. After adjusting for clin-
ical tumor stage, clinical nodal stage, tumor grade and year of surgery, there
continued to be a strong association between DTAV and pCR (P = 0.008).
The bimodal distribution of tumor response to neoadjuvant therapy
resulted in a lower odds ratio of pCR for tumors ≤ 4cm and >8 cm from the
anal verge.
Conclusions: We demonstrate a bimodal distribution of pCR based on
DTAV. Patients with low tumors (<4cm) and those with higher tumors (>8
cm), were less likely to have a pCR. Further investigation is warranted to
